Single-Cell RNA Sequencing for Biomarker Discovery in Triple-Negative and HER2+ Breast Cancer
Even with the current advances in breast cancer research, many challenges remain regarding early detection and effective treatment selection for subtypes such as triple-negative breast cancer (TNBC) and HER2-positive (HER2+). Specifically, TNC is one of the most aggressive cancer subtypes and is characterized by having...